SAN FRANCISCO – Diagnostics are notoriously tough as a business. But the lineup of successful companies that are hitting some of those big benchmarks just seems to be getting longer. A couple of superstars on this front, colorectal cancer screening company Exact Sciences Corp. and immune system-focused Adaptive Biotechnologies Corp. were featured on a panel about this topic at the J.P. Morgan (JPM) Healthcare Conference.